Supriya Lifescience Ltd (SUPRIYA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "689.70",
    "chg": 22.95,
    "chgp": "3.44%",
    "dir": 1,
    "prev_price": "666.75",
    "mcapval": "5,533.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE07RO01027",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.62 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Supriya Lifesci. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-supriya-lifesci-technically-bullish-or-bearish-3745727",
        "imagepath": "",
        "date": "2025-12-04 08:50:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Recent Price Movements</strong></p>\n<p>As of 3 December 2025, Supriya Lifescience closed at ₹755.60, marking a modest gain from the previous close of ₹745.85. The stock’s intraday range on the same day was between ₹735.75 and ₹755.60, reflecting a relatively stable trading session. Over the past 52 weeks, the share price has fluctuated between a low of ₹556.85 and a high of ₹841.70, indicating a significant price range and volatility typical of mid-cap pharmaceutical stocks.</p>\n<p><strong>Technical Indicators: A Mixed but Bullish Picture</strong></p>\n<p>The technical trend upgrade to bullish is supported by several key indicators. On the weekly timeframe, the Moving Average Convergence Divergence (MACD) is bullish, signalling positive momentum. This contrasts with the monthly MA..."
      },
      {
        "title": "Supriya Lifescience Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-returns-3745543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_technicaldot_3745543.png",
        "date": "2025-12-04 08:12:32",
        "description": "Supriya Lifescience has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and neutral signals across key indicators. The stock’s recent price movements and technical parameters suggest evolving market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-technical-momentum-shifts-amid-mixed-market-signals-3740424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_technicaldot_3740424.png",
        "date": "2025-12-02 08:12:31",
        "description": "Supriya Lifescience, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. Recent market data reveals a transition from a bullish to a mildly bullish trend, with mixed signals from MACD, RSI, and moving averages suggesting a cautious outlook for investors."
      },
      {
        "title": "Supriya Lifesci. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifesci-upgraded-to-hold-by-marketsmojo-on-improved-fundamentals-3735366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SupriyaLifesci_mojoScore_3735366.png",
        "date": "2025-11-28 10:04:56",
        "description": "Supriya Lifesci., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of steady management efficiency, valuation concerns, and a mixed performance trend over recent periods."
      },
      {
        "title": "Why is Supriya Lifesci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-supriya-lifesci-fallingrising-3722285",
        "imagepath": "",
        "date": "2025-11-22 01:27:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Performance and Market Comparison</strong></p>\n<p>Supriya Lifescience’s recent price action has been subdued relative to broader market indices. Over the past week, the stock has declined by 5.43%, contrasting sharply with the Sensex’s gain of 0.79% during the same period. This divergence highlights a lack of positive momentum in the stock compared to the benchmark. Even over the last month, the stock’s modest 1.42% decline contrasts with the Sensex’s 0.95% rise, signalling persistent short-term weakness.</p>\n<p>While the stock has delivered impressive returns over the longer term—posting a 204.50% gain over three years, significantly outperforming the Sensex’s 39.39%—the recent price drop suggests investors are cautious in the near term. Year-to-date, Supriya Lifescience ha..."
      },
      {
        "title": "Why is Supriya Lifesci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-supriya-lifesci-fallingrising-3699724",
        "imagepath": "",
        "date": "2025-11-13 23:47:59",
        "description": "As of 13-Nov, Supriya Lifescience Ltd's stock price is rising, currently at Rs 785.50, reflecting an increase of Rs 24.05 or 3.16%. The stock has shown strong performance today, outperforming its sector by 2.95% and has been on a consecutive gain streak for the last two days, accumulating a total return of 5.68%. It opened with a significant gain of 5.04% and reached an intraday high of Rs 823.3, which is an 8.12% increase. Over the past year, the stock has delivered impressive returns of 27.66%, significantly outperforming the BSE500 index over various time frames, including 3 years, 1 year, and 3 months. Additionally, the company boasts high management efficiency with a return on equity (ROE) of 17.74% and maintains a low debt-to-equity ratio, which supports its positive outlook.\n\nIn the broader market context, Supriya Lifescience's short-term return of 0.85% over the past week is slightly below the bench..."
      },
      {
        "title": "Supriya Lifescience Reports Record Financial Performance Amidst Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifesciences-financial-trend-improves-from-negative-to-flat-amid-stabilizing-metrics-3697470",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SupriyaLifescie_fintrenddot_3697470.png",
        "date": "2025-11-13 11:04:28",
        "description": "Supriya Lifescience has reported strong financial results for the quarter ending September 2025, achieving record net sales, PBDIT, and profit after tax. The company has shown resilience in the market, outperforming the Sensex in various timeframes, indicating effective navigation of its market position and robust operational performance."
      },
      {
        "title": "Supriya Lifescience Hits Day High with 7.93% Surge in Strong Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-hits-day-high-with-793-surge-in-strong-performance-3697232",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SupriyaLifescie_priceRelatedfactors_3697232.png",
        "date": "2025-11-13 10:36:03",
        "description": "Supriya Lifescience has experienced notable gains today, reaching an intraday high and outperforming its sector. The small-cap pharmaceutical company has shown consistent growth over the past two days, with strong market momentum reflected in its trading above key moving averages. The broader market also shows positive trends."
      },
      {
        "title": "How has been the historical performance of Supriya Lifesci.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-supriya-lifesci-3695705",
        "imagepath": "",
        "date": "2025-11-13 00:36:16",
        "description": "Answer:\nThe historical performance of Supriya Lifesci shows significant growth in net sales and profitability over the years, culminating in the fiscal year ending March 2025.\n\nBreakdown:\nSupriya Lifesci's net sales have increased from 311.64 Cr in March 2020 to 696.49 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 311.64 Cr in March 2020 to 696.49 Cr in March 2025. The company's operating profit (PBDIT) has also shown substantial growth, reaching 270.62 Cr in March 2025, up from 109.45 Cr in March 2020. Profit before tax increased from 96.20 Cr in March 2020 to 248.48 Cr in March 2025, while profit after tax rose from 73.37 Cr to 187.96 Cr in the same period. The earnings per share (EPS) improved significantly, from 10.02 in March 2020 to 23.35 in March 2025. On the balance sheet, total assets grew from 336.15 Cr in March 2020 to 1,112...."
      }
    ],
    "total": 263,
    "sid": "1003587",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations 2018 for quarter ended December 31 20205 is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "30-Dec-2025",
      "details": "Intimation on Credit Rating to the Company is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "26-Nov-2025",
      "details": "Pursuant to the relevant provisions of the SEBI Listing Regulations we would like to inform you that the officials of our Company Supriya Lifescience Limited (Company) will be interacting with Analyst/Institutional Investors on Tuesday December 2 2025 as per details attached herewith. Kindly take the same on record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Supriya Lifesci. technically bullish or bearish?

2025-12-04 08:50:22

Overview of Recent Price Movements As of 3 December 2025, Supriya Lifescience closed at ₹755.60, marking a modest gain from the previous close of ₹745.85. The stock’s intraday range on the same day was between ₹735.75 and ₹755.60, reflecting a relatively stable trading session. Over the past 52 weeks, the share price has fluctuated between a low of ₹556.85 and a high of ₹841.70, indicating a significant price range and volatility typical of mid-cap pharmaceutical stocks. Technical Indicators: A Mixed but Bullish Picture The technical trend upgrade to bullish is supported by several key indicators. On the weekly timeframe, the Moving Average Convergence Divergence (MACD) is bullish, signalling positive momentum. This contrasts with the monthly MA...

Supriya Lifescience Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:12:32

Supriya Lifescience has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and neutral signals across key indicators. The stock’s recent price movements and technical parameters suggest evolving market sentiment within the Pharmaceuticals & Biotechnology sector.

Supriya Lifescience Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-02 08:12:31

Supriya Lifescience, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of indicator signals across multiple timeframes. Recent market data reveals a transition from a bullish to a mildly bullish trend, with mixed signals from MACD, RSI, and moving averages suggesting a cautious outlook for investors.

Supriya Lifesci. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-28 10:04:56

Supriya Lifesci., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of steady management efficiency, valuation concerns, and a mixed performance trend over recent periods.

Why is Supriya Lifesci. falling/rising?

2025-11-22 01:27:28

Short-Term Price Performance and Market Comparison Supriya Lifescience’s recent price action has been subdued relative to broader market indices. Over the past week, the stock has declined by 5.43%, contrasting sharply with the Sensex’s gain of 0.79% during the same period. This divergence highlights a lack of positive momentum in the stock compared to the benchmark. Even over the last month, the stock’s modest 1.42% decline contrasts with the Sensex’s 0.95% rise, signalling persistent short-term weakness. While the stock has delivered impressive returns over the longer term—posting a 204.50% gain over three years, significantly outperforming the Sensex’s 39.39%—the recent price drop suggests investors are cautious in the near term. Year-to-date, Supriya Lifescience ha...

Why is Supriya Lifesci. falling/rising?

2025-11-13 23:47:59

As of 13-Nov, Supriya Lifescience Ltd's stock price is rising, currently at Rs 785.50, reflecting an increase of Rs 24.05 or 3.16%. The stock has shown strong performance today, outperforming its sector by 2.95% and has been on a consecutive gain streak for the last two days, accumulating a total return of 5.68%. It opened with a significant gain of 5.04% and reached an intraday high of Rs 823.3, which is an 8.12% increase. Over the past year, the stock has delivered impressive returns of 27.66%, significantly outperforming the BSE500 index over various time frames, including 3 years, 1 year, and 3 months. Additionally, the company boasts high management efficiency with a return on equity (ROE) of 17.74% and maintains a low debt-to-equity ratio, which supports its positive outlook. In the broader market context, Supriya Lifescience's short-term return of 0.85% over the past week is slightly below the bench...

Supriya Lifescience Reports Record Financial Performance Amidst Market Fluctuations

2025-11-13 11:04:28

Supriya Lifescience has reported strong financial results for the quarter ending September 2025, achieving record net sales, PBDIT, and profit after tax. The company has shown resilience in the market, outperforming the Sensex in various timeframes, indicating effective navigation of its market position and robust operational performance.

Supriya Lifescience Hits Day High with 7.93% Surge in Strong Performance

2025-11-13 10:36:03

Supriya Lifescience has experienced notable gains today, reaching an intraday high and outperforming its sector. The small-cap pharmaceutical company has shown consistent growth over the past two days, with strong market momentum reflected in its trading above key moving averages. The broader market also shows positive trends.

How has been the historical performance of Supriya Lifesci.?

2025-11-13 00:36:16

Answer: The historical performance of Supriya Lifesci shows significant growth in net sales and profitability over the years, culminating in the fiscal year ending March 2025. Breakdown: Supriya Lifesci's net sales have increased from 311.64 Cr in March 2020 to 696.49 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 311.64 Cr in March 2020 to 696.49 Cr in March 2025. The company's operating profit (PBDIT) has also shown substantial growth, reaching 270.62 Cr in March 2025, up from 109.45 Cr in March 2020. Profit before tax increased from 96.20 Cr in March 2020 to 248.48 Cr in March 2025, while profit after tax rose from 73.37 Cr to 187.96 Cr in the same period. The earnings per share (EPS) improved significantly, from 10.02 in March 2020 to 23.35 in March 2025. On the balance sheet, total assets grew from 336.15 Cr in March 2020 to 1,112....

View All News